⌕
iRhythm Holdings · IRTC · Nasdaq
Tenet 36 · Weak
Compare
$89.67−1.28%At closeTenet 36 · Weak
$89.67−1.17 (−1.28%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

iRhythm Holdings (IRTC) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineGrowing fast: revenue compounds ~23.3%/yr (FY21→FY25), net margin −6.0%. Worth your attention in FY25: Share count (+9.1%). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲26.2%
747.1
FY21→FY25CAGR +23.3%/yr
Net income ($M)▲60.7%
−44.6
FY21→FY25CAGR —
Free cash flow ($M)—
34.5
FY21→FY25CAGR —
Diluted EPS▲61.7%
−1.39
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+9.1%

29.3mn → 32.0mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.

Capex
$46.3M

+36.5% YoY in FY25 · 6.2% of revenue.

Returns vs FCF
0%

$0.0M returned vs $34.5M of FCF in FY25. Buybacks covered by cash flow.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)747.1Revenue−219.9COGS527.3Gross profit−87.6R&D−492.6SG&A−57.4Op income12.9Tax & other−44.6Net income

-6¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.

Margin trend · direction beats level Gross Operating Net
806040200%sector median net margin ~3%FY21FY25

Over this window: gross 66.2% → 70.6%. Net margin -6.0% is below the sector median.

The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
854,044.0747,138.0591,839.0492,681.0410,921.0322,825.0▲26.2%+23.3%
Cost of revenue
236,937.0219,888.0184,308.0160,875.0129,289.0109,258.0▲19.3%+19.1%
Gross profit
617,107.0527,250.0407,531.0331,806.0281,632.0213,567.0▲29.4%+25.3%
Research & development
84,484.087,646.0103,830.060,244.046,610.038,671.0▼15.6%+22.7%
Selling, general & admin
515,179.0492,553.0418,565.0385,645.0322,198.0274,839.0▲17.7%+15.7%
Total operating expenses
666,103.0584,657.0523,036.0456,967.0395,416.0313,510.0▲11.8%+16.9%
Operating incomefeeds ROC rank
−48,996.0−57,407.0−115,505.0−125,161.0−113,784.0−99,943.0▲50.3%—
Other income, net
11,357.013,809.02,781.02,505.0−2,102.0−1,051.0——
Pretax income
−37,639.0−43,598.0−112,724.0−122,656.0−115,886.0−100,994.0▲61.3%—
Income tax
971.0953.0565.0750.0269.0367.0▲68.7%+26.9%
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings
−38,586.0−44,551.0−113,289.0−123,406.0−116,155.0−101,361.0▲60.7%—
Per share
Diluted EPSbuyback-sensitive
−1.16−1.39−3.63−4.04−3.88−3.46▲61.7%—
Diluted shares (mn)
33.1032.0031.2030.5329.9229.33▲2.6%+2.2%
Margins
Gross margin63rd pct in Healthcare
72.3%70.6%68.9%67.3%68.5%66.2%▲1.7pp+4.4pp
Operating margin
−5.7%−7.7%−19.5%−25.4%−27.7%−31.0%▲11.8pp+23.3pp
Net margin32nd pct in Healthcare
−4.5%−6.0%−19.1%−25.0%−28.3%−31.4%▲13.2pp+25.4pp
† TTM = trailing four quarters through 2026-09-30.
FY14 – FY20 · 7 more years
Unlock the full history →
5 more years of statements and CSV export are on Premium, and 7 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-19 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was iRhythm Holdings' revenue last fiscal year?

iRhythm Holdings reported revenue of $747.1M in fiscal 2025, up 26.2% from fiscal 2024.

What was iRhythm Holdings' net income?

iRhythm Holdings reported net income of −$44.6M in fiscal 2025, a net margin of −6.0%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.